Current Status and Global Application of Immune Checkpoint Inhibitor Therapy in Endometrial Cancer

Gain insights from international experts on current best practice and emerging strategies for immune checkpoint inhibition in patients with endometrial cancer.

This educational program is intended for clinicians practicing medicine outside of the United States.

Share

Program Content

No activities added yet

No activities added yet

Supporters

Supported by an educational grant from

GlaxoSmithKline